| epirubicin / Generic mfg. |
NCT00003852: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors |
|
|
| Terminated | 2 | 45 | Europe | filgrastim, carboplatin, cyclophosphamide, epirubicin hydrochloride, etoposide, ifosfamide, paclitaxel, thiotepa, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation | UNICANCER | Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor | 03/00 | 03/00 | | |
NCT00017186: Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma |
|
|
| Completed | 2 | 69 | US | epirubicin hydrochloride, gemcitabine hydrochloride | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Malignant Mesothelioma | 08/04 | 05/08 | | |
NCT00062296: Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia |
|
|
| Completed | 2 | 5 | US | rituximab, epirubicin hydrochloride | Fox Chase Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma | 08/05 | 08/05 | | |
NCT00058487: Epirubicin and Thalidomide in Treating Patients With Liver Cancer |
|
|
| Completed | 2 | 12 | US | epirubicin hydrochloride, thalidomide | Dana-Farber Cancer Institute, National Cancer Institute (NCI) | Liver Cancer | | 01/07 | | |
NCT00198172: Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors |
|
|
| Terminated | 2 | 37 | US | Cisplatin plus Epirubicin | Indiana University School of Medicine, Indiana University | Germ Cell Tumor | | 03/07 | | |
NCT00057980: Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma |
|
|
| Completed | 1/2 | 8 | US | celecoxib, epirubicin hydrochloride | Northwestern University, National Cancer Institute (NCI) | Liver Cancer | 02/07 | 02/07 | | |
EOXP, NCT00667420: Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma |
|
|
| Terminated | 1/2 | 17 | US | panitumumab, epirubicin, oxaliplatin, xeloda | Massachusetts General Hospital | Esophageal Adenocarcinoma, Gastric Adenocarcinoma | 06/11 | 06/14 | | |
